ReShape Lifesciences (Formally known as EnteroMedics)

280 articles about ReShape Lifesciences (Formally known as EnteroMedics)

• EnteroMedics Announces 40% Reduction in Workforce

  10/29/2009

• EnteroMedics Announces Third Quarter 2009 Financial Results

  10/23/2009

• EnteroMedics Obesity Treatment Device Not Effective; Shares Dip

  10/5/2009

• EnteroMedics Announces $4.9 Million Financing

  10/5/2009

• EnteroMedics Appoints Dan Cohen as Senior Vice President of Government Relations and Health Policy

  9/25/2009

• EnteroMedics to Present at the 29th Annual Canaccord Adams Global Growth Conference

  8/5/2009

• EnteroMedics is Added to the Russell 3000(R) Index

  6/30/2009

• EnteroMedics to Present at the Canaccord Adams Annual Diabetes and Obesity Conference

  5/5/2009

• EnteroMedics Reports First Quarter 2009 Financial Results

  4/24/2009

• EnteroMedics Receives CE Mark Certification for the Maestro System for Obesity Therapy

  3/9/2009

• EnteroMedics Inc. Elects Jon T. Tremmel to Board of Directors

  1/29/2009

• EnteroMedics Inc. Announces Eighteen-Month Excess Weight Loss Results from its VBLOC-RF2 Feasibility Study

  1/12/2009

• EnteroMedics Inc. to Present at the 27th Annual JP Morgan Healthcare Conference

  1/6/2009

• EnteroMedics Inc. Announces Reduction in Workforce

  12/2/2008

• EnteroMedics Inc. Announces $20 Million Debt Financing

  11/24/2008

• EnteroMedics Inc. Reports Third Quarter 2008 Financial Results

  10/22/2008

• EnteroMedics Inc. Release: Data On VBLOC™ Therapy in Diabetes and Hypertension Presented at IFSO 13th World Congress on Obesity Surgery

  9/26/2008

• EnteroMedics Inc. to Host Conference Call after Presentation at the IFSO 13th World Congress on Obesity Surgery

  9/19/2008

• EnteroMedics Inc. Announces Management Changes within the Clinical Department

  9/18/2008

• EnteroMedics Inc. Announce Vice President of Medical Affairs and Chief Medical Officer Resign

  9/18/2008